Premium
Comments on: Chemotherapy‐based approach is the preferred treatment for sporadic late‐onset nemaline myopathy with a monoclonal protein
Author(s) -
Naddaf Elie,
Kourelis Taxiarchis
Publication year - 2021
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.33572
Subject(s) - nemaline myopathy , medicine , chemotherapy , myopathy , oncology , monoclonal antibody , pediatrics , antibody , immunology